Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LXRX

Lexicon Pharmaceuticals Inc

Jun 18 • 04:00PM ET

2.01

-0.03 -1.47 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL RYTM INCY KRYS VKTX BMRN AXSM MDGL NBIX

| Held by: VTI VXF SCHA VHT PRFZ BBC SCHB QQQS PILL BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.07	Insider Own	51.75%	Shs Outstand	423.77M	Perf Week	6.35%
Market Cap	892.83M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	0.90%	Shs Float	214.31M	Perf Month	-5.63%
Enterprise Value	779.88M	PEG	-	EPS next Q	-0.05	Inst Own	29.26%	Short Float	12.23%	Perf Quarter	24.07%
Income	-26.09M	P/S	12.82	EPS this Y	-13.33%	Inst Trans	9.83%	Short Ratio	10.62	Perf Half Y	67.50%
Sales	69.64M	P/B	4.20	EPS next Y	-30.01%	ROA	-9.21%	Short Interest	26.21M	Perf YTD	74.78%
Book/sh	0.48	P/C	5.23	EPS next 5Y	12.50%	ROE	-16.01%	52W High	2.53 -20.55%	Perf Year	169.62%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	39.13% 23.47%	ROIC	-10.08%	52W Low	0.70 185.92%	Perf 3Y	-16.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	610.25% 15.72%	Gross Margin	98.70%	Volatility	5.96% 6.25%	Perf 5Y	-56.68%
Dividend TTM	-	EV/Sales	11.20	EPS Y/Y TTM	86.10%	Oper. Margin	-34.79%	ATR (14)	0.12	Perf 10Y	-84.92%
Dividend Ex-Date	-	Quick Ratio	18.77	Sales Y/Y TTM	123.12%	Profit Margin	-37.46%	RSI (14)	53.01	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	18.79	EPS Q/Q	96.28%	SMA20	0.40%	Beta	1.08	Target Price	3.77
Payout	-	Debt/Eq	0.28	Sales Q/Q	1572.11%	SMA50	4.39%	Rel Volume	1.59	Prev Close	2.04
Employees	81	LT Debt/Eq	0.28	Earnings	May 07 BMO	SMA200	31.95%	Avg Volume	2.47M	Price	2.01
IPO	Apr 07, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.00% 115.55%	Trades		Volume	3,924,081	Change	-1.47%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)